Clinical and Inflammatory Phenotyping

Can Electronic Nose and NMR-based Metabolomics Work at the Bedside?

Mauro Maniscalco, Andrea Motta

Research output: Contribution to journalArticle

Abstract

Electronic nose (eNose) and nuclear magnetic resonance (NMR)-based metabolomics seem to be able to identify metabolic and inflammatory profiles in patients with chronic obstructive diseases. The hypothesis arises from three recent studies using two different methods in patients with asthma and chronic obstructive pulmonary diseases (COPD), opening promising diagnostic perspectives. The possibility that the use of eNose and NMR-based metabolomics might provide clinical/inflammatory characteristics is intriguing. This might classify specific phenotypes of chronic airway disease regardless of the diagnosis asthma or COPD, therefore suggesting therapeutical targets for a personalized respiratory medicine through more efficient "tailored" strategies.

Original languageEnglish
Pages (from-to)74-76
Number of pages3
JournalArchives of Medical Research
Volume49
Issue number1
DOIs
Publication statusPublished - Jan 2018

Fingerprint

Electronic Nose
Metabolomics
Chronic Obstructive Pulmonary Disease
Chronic Disease
Magnetic Resonance Spectroscopy
Asthma
Pulmonary Medicine
Precision Medicine
Metabolome
Phenotype

Cite this

Clinical and Inflammatory Phenotyping : Can Electronic Nose and NMR-based Metabolomics Work at the Bedside? / Maniscalco, Mauro; Motta, Andrea.

In: Archives of Medical Research, Vol. 49, No. 1, 01.2018, p. 74-76.

Research output: Contribution to journalArticle

@article{c1a32f9d7e574cba90281fc30454939a,
title = "Clinical and Inflammatory Phenotyping: Can Electronic Nose and NMR-based Metabolomics Work at the Bedside?",
abstract = "Electronic nose (eNose) and nuclear magnetic resonance (NMR)-based metabolomics seem to be able to identify metabolic and inflammatory profiles in patients with chronic obstructive diseases. The hypothesis arises from three recent studies using two different methods in patients with asthma and chronic obstructive pulmonary diseases (COPD), opening promising diagnostic perspectives. The possibility that the use of eNose and NMR-based metabolomics might provide clinical/inflammatory characteristics is intriguing. This might classify specific phenotypes of chronic airway disease regardless of the diagnosis asthma or COPD, therefore suggesting therapeutical targets for a personalized respiratory medicine through more efficient {"}tailored{"} strategies.",
author = "Mauro Maniscalco and Andrea Motta",
note = "Copyright {\circledC} 2018 IMSS. Published by Elsevier Inc. All rights reserved.",
year = "2018",
month = "1",
doi = "10.1016/j.arcmed.2018.04.001",
language = "English",
volume = "49",
pages = "74--76",
journal = "Archives of Medical Research",
issn = "0188-4409",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Clinical and Inflammatory Phenotyping

T2 - Can Electronic Nose and NMR-based Metabolomics Work at the Bedside?

AU - Maniscalco, Mauro

AU - Motta, Andrea

N1 - Copyright © 2018 IMSS. Published by Elsevier Inc. All rights reserved.

PY - 2018/1

Y1 - 2018/1

N2 - Electronic nose (eNose) and nuclear magnetic resonance (NMR)-based metabolomics seem to be able to identify metabolic and inflammatory profiles in patients with chronic obstructive diseases. The hypothesis arises from three recent studies using two different methods in patients with asthma and chronic obstructive pulmonary diseases (COPD), opening promising diagnostic perspectives. The possibility that the use of eNose and NMR-based metabolomics might provide clinical/inflammatory characteristics is intriguing. This might classify specific phenotypes of chronic airway disease regardless of the diagnosis asthma or COPD, therefore suggesting therapeutical targets for a personalized respiratory medicine through more efficient "tailored" strategies.

AB - Electronic nose (eNose) and nuclear magnetic resonance (NMR)-based metabolomics seem to be able to identify metabolic and inflammatory profiles in patients with chronic obstructive diseases. The hypothesis arises from three recent studies using two different methods in patients with asthma and chronic obstructive pulmonary diseases (COPD), opening promising diagnostic perspectives. The possibility that the use of eNose and NMR-based metabolomics might provide clinical/inflammatory characteristics is intriguing. This might classify specific phenotypes of chronic airway disease regardless of the diagnosis asthma or COPD, therefore suggesting therapeutical targets for a personalized respiratory medicine through more efficient "tailored" strategies.

U2 - 10.1016/j.arcmed.2018.04.001

DO - 10.1016/j.arcmed.2018.04.001

M3 - Article

VL - 49

SP - 74

EP - 76

JO - Archives of Medical Research

JF - Archives of Medical Research

SN - 0188-4409

IS - 1

ER -